ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis

L P Vaites1, Z Lian1, E K Lee1

  • 11] The Leonard and Madlyn Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA [2] Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA.

Oncogene
|January 16, 2013
PubMed

Insights

Nuclear cyclin D1 retention drives cancer by causing DNA damage and genomic instability. Inactivating ATM in mice accelerates lymphoma development, highlighting a link between DNA repair, cyclin D1, and cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cyclin D1 deregulation is a key factor in human cancer development.
  • Nuclear cyclin D1 retention during S-phase causes DNA re-replication and genomic instability.
  • This instability is linked to aberrant cyclin D1/CDK4 activity, transcriptional dysregulation, and DNA double-strand break (DSB) induction.

Purpose of the Study:

  • To investigate the synergistic effects of constitutively nuclear cyclin D1 expression and impaired DNA double-strand break (DSB) checkpoint integrity.
  • To determine if inactivating critical checkpoint mediators augments cyclin D1-dependent tumorigenesis in vivo.

Main Methods:

  • Generated and evaluated Ataxia Telangiectasia Mutated (ATM)-deficient mice harboring the Eμ-D1T286A transgene for tumor onset.
  • Compared tumor incidence and chromosomal alterations in Eμ-D1T286A/ATM-/- mice with control cohorts (Eμ-D1T286A and ATM-/-).

Main Results:

  • Mice with both Eμ-D1T286A transgene and ATM deficiency (Eμ-D1T286A/ATM-/-) showed significantly accelerated B- and T-cell lymphoma incidence.
  • Lymphomas in these mice displayed distinct clonal chromosomal alterations, particularly at the c-Myc locus, unlike ATM-/- mice which typically showed Tcrα/δ locus translocations.
  • Nuclear cyclin D1/CDK4 activity drives genomic instability in the absence of ATM function, leading to c-Myc locus alterations and tumor formation.

Conclusions:

  • Nuclear cyclin D1/CDK4 activity is a critical driver of genomic instability when ATM function is compromised.
  • This interplay facilitates the clonal selection of cells with c-Myc locus alterations, promoting neoplastic transformation and tumor development.
  • Findings reveal a complex relationship between cyclin D1, ATM, and c-Myc in cancer pathogenesis.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...